Read by QxMD icon Read


Sandra Marchese Johnson, Paul LeVine
OBJECTIVES: This survey program was designed to evaluate patients' experiences with doxycycline, USP, 40 mg capsules (30 mg immediate release, 10 mg delayed release beads, ORACEA®; Galderma Laboratories, L.P.) as a treatment for the inflammatory lesions of rosacea and to provide patient-reported feedback to physicians. METHODS: This prospective, cross-sectional survey was implemented in January 2010. One thousand, two hundred and ninety-five physicians identified patients eligible for treatment with doxycycline, USP, 40 mg capsules and provided them with information about the program...
December 2011: Journal of Drugs in Dermatology: JDD
Guy F Webster
Rosacea is a common inflammatory disorder of the skin of middle-aged and older adults. A unique 40-mg formulation of doxycycline (30-mg immediate-release and 10-mg delayed-release beads) developed for its anti-inflammatory properties is the only US Food and Drug Administration-approved oral medication for the disorder. This report describes the results of the Oracea for Rosacea: A Community-Based Assessment (ORCA) trial, a phase 4 trial of the 40-mg formulation as monotherapy in adults with mild to severe papulopustular rosacea...
November 2010: Cutis; Cutaneous Medicine for the Practitioner
James Q Del Rosso
No abstract text is available yet for this article.
November 2010: Cutis; Cutaneous Medicine for the Practitioner
Ronald D Wise
Rosacea is a disease of inflammation with no pathogenic bacteria involved. Successful treatment of rosacea is possible without using antimicrobial preparations. Oracea capsules provide the antiinflammatory benefits of doxycycline without contributing to the development of resistance to doxycycline.
2007: Comprehensive Therapy
Brian Berman, Oliver A Perez, Deborah Zell
Approximately 13 million individuals in the United Sates suffer from rosacea, a recurrent disease that may require long-term therapy. Topical and oral antibiotics have been used to treat rosacea; however, high-dose antibiotics or long-term, low-dose antibiotics commonly used for the treatment of rosacea flares or for rosacea maintenance therapy, respectively, can lead to the development of antibiotic-resistant organisms. The first oral medication approved by the U.S. Food and Drug Administration for the treatment of rosacea in the United States is Oracea (CollaGenex Pharmaceuticals Inc...
January 2007: Drugs of Today
(no author information available yet)
No abstract text is available yet for this article.
January 15, 2007: Medical Letter on Drugs and Therapeutics
Amy Perlmutter, William Abramovits, Aditya K Gupta
No abstract text is available yet for this article.
September 2006: Skinmed
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"